Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Cash from Financing Activities (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Cash from Financing Activities for 16 consecutive years, with $8.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 50.29% to $8.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $20.7 million, a 10.52% decrease, with the full-year FY2024 number at $23.8 million, up 484.64% from a year prior.
  • Cash from Financing Activities was $8.1 million for Q3 2025 at GeoVax Labs, up from $209.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.5 million in Q2 2022 to a low of -$25801.0 in Q2 2021.
  • A 5-year average of $7.1 million and a median of $7.6 million in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: plummeted 102.44% in 2021, then skyrocketed 71796.88% in 2022.
  • GeoVax Labs' Cash from Financing Activities stood at $230000.0 in 2021, then soared by 3215.45% to $7.6 million in 2022, then crashed by 46.73% to $4.1 million in 2023, then grew by 14.91% to $4.7 million in 2024, then soared by 74.11% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Cash from Financing Activities are $8.1 million (Q3 2025), $209.0 (Q2 2025), and $7.9 million (Q1 2025).